title: Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
authors.forename: G
authors.initials: G
authors.lastname: Orlando
authors.forename: M M
authors.initials: MM
authors.lastname: Fasolo
authors.forename: R
authors.initials: R
authors.lastname: Beretta
authors.forename: R
authors.initials: R
authors.lastname: Signori
authors.forename: B
authors.initials: B
authors.lastname: Adriani
authors.forename: N
authors.initials: N
authors.lastname: Zanchetta
authors.forename: A
authors.initials: A
authors.lastname: Cargnel
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D000287:Administration, Topical; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000077404:Cidofovir; D003218:Condylomata Acuminata / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004279:DNA, Viral / Q000032:analysis; D006678:HIV / Q000235:genetics; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D027383:Papillomaviridae / Q000235:genetics; D030361:Papillomavirus Infections / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D012008:Recurrence; D014412:Tumor Virus Infections / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir